🇺🇸 FDA
Pipeline program

EFFIMIA 0,250 mg/0,035mg, Compresse

EFFI2021/01

Approved small_molecule active

Quick answer

EFFIMIA 0,250 mg/0,035mg, Compresse for Female contraception. is a Approved program (small_molecule) at Italfarmaco S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Italfarmaco S.p.A.
Indication
Female contraception.
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials